Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PILOT TRIAL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 94 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Shin, EK; Son, JW; Sohn, MS; Jin, DK; Park, GS; Koh, KK; Ahn, TH; Choi, IS
      Efficacy of heparin-coated stent in early setting of acute myocardial infarction

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    2. Meininger, V
      Clinical trials: the past, a lesson for the future

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    3. Francis, DA
      Glatiramer acetate (Copaxone)

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    4. Andreone, P; Cursaro, C; Gramenzi, A; Margotti, M; Ferri, E; Talarico, S; Biselli, M; Felline, F; Tuthill, C; Martins, E; Gasbarrini, G; Bernardi, M
      In vitro effect of thymosin-alpha 1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C

      JOURNAL OF VIRAL HEPATITIS
    5. Adorini, L
      Selective immunointervention in autoimmune diseases: Lessons from multiplesclerosis

      JOURNAL OF CHEMOTHERAPY
    6. Dufresne, R; Liard, A; Blum, MS
      Anaerobic treatment of condensates: Trial at a kraft pulp and paper mill

      WATER ENVIRONMENT RESEARCH
    7. Hollenberg, SM
      Cardiogenic shock

      CRITICAL CARE CLINICS
    8. Hohlfeld, R; Wiendl, H
      The ups and downs of multiple sclerosis therapeutics

      ANNALS OF NEUROLOGY
    9. Comi, G; Filippi, M; Wolinsky, JS
      European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis

      ANNALS OF NEUROLOGY
    10. Vandenbark, AA; Morgan, E; Bartholomew, R; Bourdette, D; Whitham, R; Carlo, D; Gold, D; Hashim, G; Offner, H
      TCR peptide therapy in human autoimmune diseases

      NEUROCHEMICAL RESEARCH
    11. Ziemssen, T; Neuhaus, O; Hohlfeld, R
      Risk-benefit assessment of glatiramer acetate in multiple sclerosis

      DRUG SAFETY
    12. Dasgupta, A; Ramaswamy, K; Giraldo, J; Taniguchi, M; Amenta, PS; Das, KM
      Colon epithelial cellular protein induces oral tolerance in the experimental model of colitis by trinitrobenzene sulfonic acid

      JOURNAL OF LABORATORY AND CLINICAL MEDICINE
    13. Stone, GW; Cox, D; Garcia, E; Brodie, BR; Morice, MC; Griffin, J; Mattos, L; Lansky, AJ; O'Neill, WW; Grines, CL
      Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction - Analysis from the primary angioplasty in myocardial infarction trials

      CIRCULATION
    14. Poyen, V; Labrunie, P; Haddad, V; Dravet, F; Valeix, B
      Primary angioplasty associated with systematic coronary stenting in acute myocardial infarction. Series of 149 patients: Results at the end of the hospital period and at 24 months.

      ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX
    15. Singh, M; Berger, PB; Ting, HH; Rihal, CS; Wilson, SH; Lennon, RJ; Reeder, GS; Bresnahan, JF; Holmes, DR
      Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (The Mayo Clinic experience)

      AMERICAN JOURNAL OF CARDIOLOGY
    16. Angelini, C; Bonifati, DM
      New therapies in muscular dystrophies

      NEUROLOGICAL SCIENCES
    17. Dauerman, HL; Prpic, R; Andreou, C; Vu, MA; Popma, JJ
      Angiographic and clinical outcomes after rescue coronary stenting

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    18. Galli, M; Bartorelli, A; Bedogni, F; DeCesare, N; Klugmann, S; Maiello, T; Miccoli, F; Moccetti, T; Onofri, M; Paolillo, V; Pirisi, R; Presbitero, T; Sganzerla, P; Viecca, M; Zerboni, S; Lanteri, G
      Italian BiodivYsio open registry (BiodivYsio PC-coated stent): Study of clinical outcomes of the implant of a PC-coated coronary stent

      JOURNAL OF INVASIVE CARDIOLOGY
    19. Arjomand, H; Mascarenhas, DAN
      Combination of abciximab with primary stenting in patients with acute myocardial infarction: A community hospital experience

      JOURNAL OF INVASIVE CARDIOLOGY
    20. Andersson, PO; Stockelberg, D; Jacobsson, S; Wadenvik, H
      A transforming growth factor-beta 1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura

      ANNALS OF HEMATOLOGY
    21. Dauerman, HL; Andreou, C; Perras, MA; Spinner, JS; Lessard, D; Weiner, BH
      Predictors of bleeding complications after rescue coronary interventions

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    22. Fujise, K; Yhip, PA; Anderson, HV; Schroth, G; Rosales, O; Smalling, RW
      Balloon to artery ratio, not inflation pressure, correlates with adequate stent deployment: Size is more important than pressure

      JOURNAL OF INTERVENTIONAL CARDIOLOGY
    23. Tolg, R; Schwill, K; Kurz, T; Hartmann, F; Katus, HA; Richardt, G
      Intracoronary stenting and left-ventricular myocardial function after primary PTCA in acute myocardial infarction

      ZEITSCHRIFT FUR KARDIOLOGIE
    24. Steel, DHW; West, J; Campbell, WG
      A randomized controlled study of the use of transscleral diode laser and cryotherapy in the management of rhegmatogenous retinal detachment

      RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
    25. Foroohar, M; Macdonald, RL; Roth, S; Stoodley, M; Weir, B
      Intraoperative variables and early outcome after aneurysm surgery

      SURGICAL NEUROLOGY
    26. La Mantia, L; Milanese, C; D'Amico, R
      Meta-analysis of clinical trials with copolymer 1 in multiple sclerosis

      EUROPEAN NEUROLOGY
    27. Bulpitt, CJ
      The Hypertension in the Very Elderly Trial: the importance of the pilot trial and modifications to the protocol

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    28. Schmidt, S
      Candidate autoantigens in multiple sclerosis

      MULTIPLE SCLEROSIS
    29. Hermans, G; Denzer, U; Lohse, A; Raus, J; Stinissen, P
      Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination

      JOURNAL OF AUTOIMMUNITY
    30. Sela, M
      Specific vaccines against autoimmune diseases

      COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES
    31. Kissel, JT
      Facioscapulohumeral dystrophy

      SEMINARS IN NEUROLOGY
    32. Tawil, R
      Outlook for therapy in the muscular dystrophies

      SEMINARS IN NEUROLOGY
    33. Zeymer, U; Neuhaus, KL
      Clinical trials in acute myocardial infarction

      CURRENT OPINION IN CARDIOLOGY
    34. Arnason, BGW
      Immunologic therapy of multiple sclerosis

      ANNUAL REVIEW OF MEDICINE
    35. van der Reijden, WA; Vissink, A; Veerman, ECI; Amerongen, AVN
      Treatment of oral dryness related complaints (xerostomia) in Sjogren's syndrome

      ANNALS OF THE RHEUMATIC DISEASES
    36. STINISSEN P; MEDAER R; RAUS J
      MYELIN REACTIVE T-CELLS IN THE AUTOIMMUNE PATHOGENESIS OF MULTIPLE-SCLEROSIS

      Multiple sclerosis
    37. Kuchroo, VK; Weiner, HL
      Antigen-driven regulation of experimental autoimmune encephalomyelitis

      RESEARCH IN IMMUNOLOGY
    38. BASHIR K; WHITAKER JN
      CURRENT IMMUNOTHERAPY IN MULTIPLE-SCLEROSIS

      Immunology and cell biology
    39. JEWELL SD; GIENAPP IE; COX KL; WHITACRE CC
      ORAL TOLERANCE AS THERAPY FOR EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS AND MULTIPLE-SCLEROSIS - DEMONSTRATION OF T-CELL ANERGY

      Immunology and cell biology
    40. POZZILLI P
      PREVENTION OF INSULIN-DEPENDENT DIABETES-MELLITUS 1998

      Diabetes/metabolism reviews
    41. SELA M
      POLY(ALPHA-AMINO ACIDS) - FROM A BETTER UNDERSTANDING OF IMMUNE PHENOMENA TO A DRUG AGAINST MULTIPLE-SCLEROSIS

      Acta polymerica
    42. FAHN S; CHOUINARD S
      EXPERIENCE WITH TRANYLCYPROMINE IN EARLY PARKINSONS-DISEASE

      Journal of neural transmission. Supplementum
    43. DANG T; GOEBELS N; WALTHER EU; HOHLFELD R
      TREATMENT OF RELAPSING-REMITTING MULTIPLE -SCLEROSIS WITH COPOLYMER-1(GLATIRAMERACETATE)

      Aktuelle Neurologie
    44. Compston, A
      Future options for therapies to limit damage and enhance recovery

      SEMINARS IN NEUROLOGY
    45. SHERMAN KE; SJOGREN M; CREAGER RL; DAMIANO MA; FREEMAN S; LEWEY S; DAVIS D; ROOT S; WEBER FL; ISHAK KG; GOODMAN ZD
      COMBINATION THERAPY WITH THYMOSIN ALPHA-1 AND INTERFERON FOR THE TREATMENT OF CHRONIC HEPATITIS-C INFECTION - A RANDOMIZED, PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL

      Hepatology
    46. DUQUESNE N; FLEURY J; BONNET M
      COMPARED RATE OF POSTOPERATIVE PROLIFERATIVE VITREO-RETINOPATHY (PVR)AFTER TRANSSCLERAL DIODE RETINOPEXY OR TRANSPUPILLARY ARGON RETINOPEXY IN RHEGMATOGENOUS RETINAL-DETACHMENT ASSOCIATED WITH PREOPERATIVE GRADE-B PVR

      Journal francais d'ophtalmologie
    47. JOHNSON KP; BROOKS BR; COHEN JA; FORD CC; GOLDSTEIN J; LISAK RP; MYERS LW; PANITCH HS; ROSE JW; SCHIFFER RB; VOLLMER T; WEINER LP; WOLINSKY JS
      EXTENDED USE OF GLATIRAMER ACETATE (COPAXONE) IS WELL TOLERATED AND MAINTAINS ITS CLINICAL EFFECT ON MULTIPLE-SCLEROSIS RELAPSE RATE AND DEGREE OF DISABILITY

      Neurology
    48. Myers, LK; Brand, DD; Ye, XJ; Cremer, MA; Rosloniec, EF; Bodo, M; Myllyharju, J; Helaakoski, T; Nokelainen, M; Pihlajaniemi, T; Kivirikko, K; Yang, CL; Alakokko, L; Prockop, DJ; Notbohm, H; Fietzek, P; Stuart, JM; Kang, AH
      Characterization of recombinant type II collagen: arthritogenicity and tolerogenicity in DBA/1 mice

      IMMUNOLOGY
    49. OXHOLM P; PRAUSE JU; SCHIODT M
      RATIONAL DRUG-THERAPY - RECOMMENDATIONS FOR THE TREATMENT OF PATIENTSWITH SJOGRENS-SYNDROME

      Drugs
    50. ZIPP F; KERSCHENSTEINER M; DORNMAIR K; MALOTKA J; SCHMIDT S; BENDER A; GIEGERICH G; MALEFYT RD; WEKERLE H; HOHLFELD R
      DIVERSITY OF THE ANTI-T-CELL RECEPTOR IMMUNE-RESPONSE AND ITS IMPLICATIONS FOR T-CELL VACCINATION THERAPY OF MULTIPLE-SCLEROSIS

      Brain (Print)
    51. KALDEN JR; SIEPER J
      ORAL COLLAGEN IN THE TREATMENT OF RHEUMATOID-ARTHRITIS

      Arthritis and rheumatism
    52. BARNETT ML; KREMER JM; STCLAIR EW; CLEGG DO; FURST D; WEISMAN M; FLETCHER MJF; CHASANTABER S; FINGER E; MORALES A; LE CH; TRENTHAM DE
      TREATMENT OF RHEUMATOID-ARTHRITIS WITH ORAL TYPE-II COLLAGEN - RESULTS OF A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

      Arthritis and rheumatism
    53. TEITELBAUM D; ARNON R; SELA M
      COPOLYMER-1 - FROM BASIC RESEARCH TO CLINICAL-APPLICATION

      Cellular and molecular life sciences
    54. TSELIS AC
      MULTIPLE-SCLEROSIS - A PHARMACOTHERAPY UPDATE

      Formulary
    55. CACERES DD; HANCKE JL; BURGOS RA; WIKMAN GK
      PREVENTION OF COMMON COLDS WITH ANDROGRAPHIS-PANICULATA DRIED EXTRACT- A PILOT DOUBLE-BLIND TRIAL

      Phytomedicine
    56. CALL HP; MUCKE I
      HISTORY, OVERVIEW AND APPLICATIONS OF MEDIATED LIGNOLYTIC SYSTEMS, ESPECIALLY LACCASE-MEDIATOR-SYSTEMS (LIGNOZYM(R)-PROCESS)

      Journal of biotechnology
    57. HUNTER SF; WEINSHENKER BG; CARTER JL; NOSEWORTHY JH
      RATIONAL CLINICAL IMMUNOTHERAPY FOR MULTIPLE-SCLEROSIS

      Mayo Clinic proceedings
    58. FAHN S
      AN OVERVIEW OF NOVEL THERAPIES FOR PARKINSONS-DISEASE

      Experimental neurology
    59. PLAITAKIS A; FESDJIAN CO; SHASHIDHARAN P
      GLUTAMATE ANTAGONISTS IN AMYOTROPHIC-LATERAL-SCLEROSIS - A REVIEW OF THEIR THERAPEUTIC POTENTIAL

      CNS DRUGS
    60. BARBER JP; FRANK A; WEISS RD; BLAINE J; SIQUELAND L; MORAS K; CALVO N; CHITTAMS J; MERCER D; SALLOUM IM
      PREVALENCE AND CORRELATES OF PERSONALITY-DISORDER DIAGNOSES AMONG COCAINE-DEPENDENT OUTPATIENTS

      Journal of personality disorders
    61. POZZILLI P
      PREVENTION OF INSULIN-DEPENDENT DIABETES - WHERE ARE WE NOW

      Diabetes/metabolism reviews
    62. LAMANTIA L; EOLI M; SALMAGGI A; MILANESE C
      DOES A PLACEBO-EFFECT EXIST IN CLINICAL-TRIALS ON MULTIPLE-SCLEROSIS - REVIEW OF THE LITERATURE

      Italian journal of neurological sciences
    63. BLIN O; AZULAY JP; DESNUELLE C; BILLETURC F; BRAGUER D; BESSE D; BRANGER E; CREVAT A; SERRATRICE G; POUGET JY
      A CONTROLLED ONE-YEAR TRIAL OF DEXTROMETHORPHAN IN AMYOTROPHIC-LATERAL-SCLEROSIS

      Clinical neuropharmacology
    64. JOHNSON KP
      COPOLYMER-1 - AN UPDATE - PROCEEDINGS OF A SYMPOSIUM HELD DURING THE 5TH ANNUAL-MEETING OF THE EUROPEAN-NEUROLOGICAL-SOCIETY - 18-19 JUNE 1995 - MUNICH, GERMANY - INTRODUCTION

      Journal of neurology
    65. JOHNSON KP
      A REVIEW OF THE CLINICAL EFFICACY PROFILE OF COPOLYMER-1 - NEW US PHASE-III TRIAL DATA

      Journal of neurology
    66. KORCZYN AD; NISIPEANU P
      SAFETY PROFILE OF COPOLYMER-1 - ANALYSIS OF CUMULATIVE EXPERIENCE IN THE UNITED-STATES AND ISRAEL

      Journal of neurology
    67. ARNON R
      THE DEVELOPMENT OF COP-1 (COPAXONE(R)), AN INNOVATIVE DRUG FOR THE TREATMENT OF MULTIPLE-SCLEROSIS - PERSONAL REFLECTIONS

      Immunology letters
    68. WEINSTOCKGUTTMAN B; COHEN JA
      NEWER VERSUS OLDER TREATMENTS FOR RELAPSING-REMITTING MULTIPLE-SCLEROSIS

      Drug safety
    69. HUGHES RAC; SHARRACK B
      MORE IMMUNOTHERAPY FOR MULTIPLE-SCLEROSIS

      Journal of Neurology, Neurosurgery and Psychiatry
    70. POHLAU D; RIEKS M; POSTERT T; HOFFMANN V; PRZUNTEK H
      CAUSAL TREATMENT OF MULTIPLE-SCLEROSIS

      Deutsche Medizinische Wochenschrift
    71. POLMAN CH; HARTUNG HP
      THE TREATMENT OF MULTIPLE-SCLEROSIS - CURRENT AND FUTURE

      Current opinion in neurology
    72. CARTER JL
      DISEASE-MODIFYING THERAPIES FOR MULTIPLE-SCLEROSIS

      CNS DRUGS
    73. JAVAHERIAN K; MCDANAL C
      RANDOM COPOLYMERS CONTAINING SPECIFIC RATIOS OF NEGATIVELY CHARGED AND AROMATIC-AMINO-ACIDS BIND V3 DISULFIDE LOOP AND NEUTRALIZE DIVERSE HIV TYPE-1 ISOLATES

      AIDS research and human retroviruses
    74. GOODKIN DE; RUDICK RA; MEDENDORP SV; DAUGHTRY MM; SCHWETZ KM; FISCHER J; VANDYKE C
      LOW-DOSE (7.5-MG) ORAL METHOTREXATE REDUCES THE RATE OF PROGRESSION IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS

      Annals of neurology
    75. KLEBER HD
      PHARMACOTHERAPY, CURRENT AND POTENTIAL, FOR THE TREATMENT OF COCAINE DEPENDENCE

      Clinical neuropharmacology
    76. FEDERICO A; BATTISTI C; FORMICHI P; DOTTI MT
      PLASMA-LEVELS OF VITAMIN-E IN PARKINSONS-DISEASE

      Journal of neural transmission. Supplementum
    77. HOHLFELD R
      MULTIPLE-SCLEROSIS

      Aktuelle Neurologie
    78. ROBBERECHT W
      NEW TREATMENT STRATEGIES IN AMYOTROPHIC-LATERAL-SCLEROSIS - SOLUTIONSOR ILLUSIONS

      Acta neurologica belgica
    79. OFFENSPERGER WB; BLUM HE; GEROK W
      THERAPY OF HEPADNAVIRUS INFECTION USING ANTISENSE OLIGONUCLEOTIDES

      Intervirology
    80. WOLINSKY JS
      COPOLYMER-1 - A MOST REASONABLE ALTERNATIVE THERAPY FOR EARLY RELAPSING-REMITTING MULTIPLE-SCLEROSIS WITH MILD DISABILITY

      Neurology
    81. JOHNSON KP; BROOKS BR; COHEN JA; FORD CC; GOLDSTEIN J; LISAK RP; MYERS LW; PANITCH HS; ROSE JW; SCHIFFER RB; VOLLMER T; WEINER LP; WOLINSKY JS; BIRD SJ; CONSTANTINESCU C; KOLSON DL; GONZALEZSCARANO F; BRENNAN D; PFOHL D; MANDLER RN; ROSENBERG GA; JEFFREY C; BARGER GR; GANDHI B; MOORE PM; ROGERS LR; LISAK D; SMITH L; ELLISON GW; BAUMHEFNER RW; CRAIG SL; JALBUT SS; KATZ E; CONWAY KL; BURNS JB; SHIBA C; GIANG DW; PETRIE MD; GUARNACCIA JB; ANDERSON S; MCKEON A; MCCARTHY M; THOMAS AB; VRIESENDORP FJ; AUSTIN SG; LINDSEY JW; DIMACHKIE M; CERRETA E; KACHUCK N; MCCARTHY KA; FLEMING J; PARNELL JH; TAMULEVICH J; WEASLER C; KADOSH S; HALT H; STARK Y; PINCHASI I; SPILLER N; VANDENNOORT S; MILLER A; MELLITS D; HOPKINS J; REINGOLD S; GOMOLIN IH
      COPOLYMER-1 REDUCES RELAPSE RATE AND IMPROVES DISABILITY IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - RESULTS OF A PHASE-III MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

      Neurology
    82. WEILBACH FX; VOLTZ R; HOHLFELD R; HARTUNG HP
      COPOLYMER-1 IN THE THERAPY OF MULTIPLE-SC LEROSIS

      Nervenarzt
    83. SUNDAR S; ROSENKAIMER F; LESSER ML; MURRAY HW
      IMMUNOCHEMOTHERAPY FOR A SYSTEMIC INTRACELLULAR INFECTION - ACCELERATED RESPONSE USING INTERFERON-GAMMA IN VISCERAL LEISHMANIASIS

      The Journal of infectious diseases
    84. JACOBS L; GOODKIN DE; RUDICK RA; HERNDON R
      ADVANCES IN SPECIFIC THERAPY FOR MULTIPLE-SCLEROSIS

      Current opinion in neurology
    85. ASKMARK H; AQUILONIUS SM
      AMYOTROPHIC-LATERAL-SCLEROSIS - PRACTICAL TREATMENT RECOMMENDATIONS

      CNS DRUGS
    86. MURRAY HW
      CYTOKINES IN THE TREATMENT OF LEISHMANIASIS

      Bailliere's clinical infectious diseases
    87. SILBERBERG DH
      SPECIFIC TREATMENT OF MULTIPLE-SCLEROSIS

      Clinical neuroscience
    88. ORRELL RW; LANE RJM; GUILOFF RJ
      RECENT DEVELOPMENTS IN THE DRUG-TREATMENT OF MOTOR-NEURON DISEASE

      BMJ. British medical journal
    89. LYONCAEN O; FONTAINE B; GOUT O; TOURBAH A
      MULTIPLE-SCLEROSIS AND OTHER RELATED INFLAMMATORY DISORDERS OF THE CENTRAL-NERVOUS-SYSTEM - DIFFERENTIAL-DIAGNOSIS AND TREATMENT

      Acta neurologica belgica
    90. EBERS GC
      TREATMENT OF MULTIPLE-SCLEROSIS

      Lancet
    91. HUGHES R
      IMMUNOTHERAPY FOR MULTIPLE-SCLEROSIS

      Journal of Neurology, Neurosurgery and Psychiatry
    92. REGENSTEIN F
      NEW APPROACHES TO THE TREATMENT OF CHRONIC VIRAL-HEPATITIS-B AND VIRAL-HEPATITIS-C

      The American journal of medicine
    93. SUDILOVSKY A; CUTLER NR; SRAMEK JJ; WARDLE T; VEROFF AE; MICKELSON W; MARKOWITZ J; REPETTI S
      A PILOT CLINICAL-TRIAL OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITORCERANAPRIL IN ALZHEIMER-DISEASE

      Alzheimer disease and associated disorders
    94. WRIGHT TL; LAU JYN
      CLINICAL ASPECTS OF HEPATITIS-B VIRUS-INFECTION

      Lancet


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/06/20 alle ore 09:59:42